Back
Day Range
$47.99
$49.20
52-Week Range
$13.22
$94.90
Volume
622,380
50D / 200D Avg
$71.72
/
$40.61
Prev Close
$47.04
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -19.6 | 0.3 |
| P/B | 1.8 | 3.0 |
| ROE % | -11.9 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$116.71
+142.5%
Low: $90.00
High: $145.00
Forward EPS
-$1.72
Est. Revenue
7.14M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.60
$1.60 – $1.60
|
854.11M | 2 |
| FY2029 |
-$0.31
-$0.31 – -$0.31
|
632.55M | 4 |
| FY2028 |
-$1.91
-$4.04 – $1.24
|
213.03M | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | -$0.06 | -$0.49 | -756.2% |
| 2025-11-06 | -$0.36 | -$0.37 | -2.8% |
| 2025-08-06 | -$0.28 | -$0.36 | -28.6% |
| 2025-05-08 | -$0.24 | -$0.27 | -12.5% |
| 2025-02-27 | -$0.23 | -$0.22 | +4.3% |
| 2024-11-13 | -$0.19 | -$0.20 | -5.3% |
| 2024-08-08 | -$0.23 | -$0.18 | +21.7% |
| 2024-05-09 | -$0.21 | -$0.19 | +9.5% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -225.81M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-11.86%
ROIC-14.16%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Current Ratio24.81
Interest Coverage0.00
Valuation
P/E Ratio
-19.62
Forward P/EN/A
P/B Ratio1.83
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -141.20M |
| ROE | -11.86% | ROA | -8.91% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -225.81M |
| ROIC | -14.16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 24.81 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -19.62 | Forward P/E | N/A |
| P/B Ratio | 1.83 | P/S Ratio | N/A |
| PEG Ratio | -11.37 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 387.90 | Fwd Earnings Yield | N/A |
| FCF Yield | -8.15% | ||
| Market Cap | 2.77B | Enterprise Value | 1.98B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -141.20M | -122.53M | -89.62M | -51.32M | -40.01M |
| EPS (Diluted) | -2.40 | -2.34 | -2.43 | -1.44 | -1.20 |
| Gross Profit | -3.90M | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -287.57M | -158.23M | -102.78M | -52.56M | -37.70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.58B | 903.33M | 482.02M | 97.85M | 111.16M |
| Total Liabilities | 67.54M | 38.49M | 29.05M | 212.99M | 175.89M |
| Shareholders' Equity | 1.52B | 864.84M | 452.97M | -115.14M | -64.74M |
| Total Debt | 6.49M | 3.86M | 5.45M | 260,000.0 | 621,000.0 |
| Cash & Equivalents | 799.62M | 169.51M | 129.79M | 26.09M | 105.31M |
| Current Assets | 1.57B | 891.21M | 473.61M | 93.09M | 109.25M |
| Current Liabilities | 63.29M | 36.02M | 24.74M | 13.01M | 8.66M |